{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oligometastatic+Lung+Tumor", "query": { "condition": "Oligometastatic Lung Tumor" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 16, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oligometastatic+Lung+Tumor&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-24T04:49:42.833Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02316002", "title": "Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oligometastatic Non-small Cell Lung Cancer (NSCLC)" ], "interventions": [ { "name": "Pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abramson Cancer Center at Penn Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2015-01-21", "completion_date": "2022-12", "has_results": true, "last_update_posted_date": "2025-11-06", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02316002" }, { "nct_id": "NCT06563388", "title": "Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Oligometastasis", "Lung Cancer", "Colo-rectal Cancer", "Prostate Cancer" ], "interventions": [ { "name": "Stereotactic Ablative Radiotherapy", "type": "PROCEDURE" }, { "name": "Best Practice", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 800, "start_date": "2024-09-18", "completion_date": "2032-09-18", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06563388" }, { "nct_id": "NCT00776100", "title": "Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "clinical observation", "type": "OTHER" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "OTHER", "RADIATION" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 3, "start_date": "2008-10", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2017-03-06", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 168, "location_summary": "Scottsdale, Arizona • Hartford, Connecticut • Jacksonville, Florida + 103 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Bloomington", "state": "Illinois" }, { "city": "Canton", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00776100" }, { "nct_id": "NCT05299606", "title": "POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Neoplasms" ], "interventions": [ { "name": "Transbronchial Microwave Ablation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ethicon, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 12, "start_date": "2022-10-21", "completion_date": "2024-10-18", "has_results": true, "last_update_posted_date": "2025-11-24", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 7, "location_summary": "Stanford, California • Farmington, Connecticut • Minneapolis, Minnesota + 4 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Pinehurst", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05299606" }, { "nct_id": "NCT06236516", "title": "One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Cancer", "Oligometastatic Lung Tumor" ], "interventions": [ { "name": "One fraction stereotactic body radiotherapy", "type": "RADIATION" }, { "name": "HyperSight", "type": "DEVICE" }, { "name": "Ethos", "type": "DEVICE" } ], "intervention_types": [ "RADIATION", "DEVICE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2024-02-26", "completion_date": "2025-08-05", "has_results": true, "last_update_posted_date": "2026-05-01", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06236516" }, { "nct_id": "NCT02170181", "title": "Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer Patients Receiving Stereotactic Body RTX" ], "interventions": [ { "name": "SBRT", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 149, "start_date": "2014-05-28", "completion_date": "2025-08", "has_results": false, "last_update_posted_date": "2025-09-17", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02170181" }, { "nct_id": "NCT05846646", "title": "Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oligometastatic Disease" ], "interventions": [ { "name": "IMSA101", "type": "DRUG" }, { "name": "Immune checkpoint inhibitor", "type": "DRUG" }, { "name": "PULSAR", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "ImmuneSensor Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2023-06-28", "completion_date": "2024-09-16", "has_results": true, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 9, "location_summary": "Irvine, California • Kansas City, Kansas • New Brunswick, New Jersey + 5 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05846646" }, { "nct_id": "NCT03808662", "title": "Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "TNBC - Triple-Negative Breast Cancer", "Triple Negative Breast Cancer", "NSCLC", "NSCLC Stage IV", "Non Small Cell Lung Cancer", "Non Small Cell Lung Cancer Metastatic", "NSCLC Stage IV Without EGFR/ALK Mutation" ], "interventions": [ { "name": "Sterotactic Body Radiotherapy/SBRT", "type": "RADIATION" }, { "name": "Standard of care", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 107, "start_date": "2019-01-16", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 9, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 6 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03808662" }, { "nct_id": "NCT01725165", "title": "Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Lung Non-Small Cell Carcinoma", "Stage IV Non-Small Cell Lung Cancer AJCC v7" ], "interventions": [ { "name": "Clinical Observation", "type": "OTHER" }, { "name": "External Beam Radiation Therapy", "type": "RADIATION" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Standard Follow-Up Care", "type": "PROCEDURE" }, { "name": "Therapeutic Conventional Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "RADIATION", "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 85, "start_date": "2012-11-28", "completion_date": "2024-05-08", "has_results": true, "last_update_posted_date": "2024-10-24", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 2, "location_summary": "Denver, Colorado • Houston, Texas", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01725165" }, { "nct_id": "NCT03808337", "title": "Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Triple Negative Breast Cancer", "Non Small Cell Lung Cancer", "Metastatic Breast Cancer", "Metastatic Non-Small Cell Lung Carcinoma" ], "interventions": [ { "name": "Stereotactic Body Radiotherapy/SBRT", "type": "RADIATION" }, { "name": "Systemic Therapy/Standard of Care", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 145, "start_date": "2019-01-16", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-07-24T04:49:42.833Z", "location_count": 12, "location_summary": "San Carlos, California • Hartford, Connecticut • Norwalk, Connecticut + 9 more", "locations": [ { "city": "San Carlos", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Norwalk", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Basking Ridge", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03808337" } ] }